VECTICAL Drug Patent Profile
✉ Email this page to a colleague
When do Vectical patents expire, and what generic alternatives are available?
Vectical is a drug marketed by Galderma Labs Lp and is included in one NDA.
The generic ingredient in VECTICAL is calcitriol. There are ten drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vectical
A generic version of VECTICAL was approved as calcitriol by TEVA on October 12th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VECTICAL?
- What are the global sales for VECTICAL?
- What is Average Wholesale Price for VECTICAL?
Summary for VECTICAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 4 |
Patent Applications: | 4,220 |
Drug Prices: | Drug price information for VECTICAL |
What excipients (inactive ingredients) are in VECTICAL? | VECTICAL excipients list |
DailyMed Link: | VECTICAL at DailyMed |
Recent Clinical Trials for VECTICAL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | Phase 4 |
Emer, Jason, M.D. | Phase 4 |
Galderma Laboratories | Phase 4 |
Pharmacology for VECTICAL
Drug Class | Vitamin D3 Analog |
US Patents and Regulatory Information for VECTICAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galderma Labs Lp | VECTICAL | calcitriol | OINTMENT;TOPICAL | 022087-001 | Jan 23, 2009 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |